Ben Brzezynski has been involved in several early stage health technology companies from ideation to commercialization for 13 years.

Ben has held commercial leadership roles with Canadian, US and UK companies, focusing heavily on applications of artificial intelligence in medicine, digital biomarker discovery, digital therapeutics and advancements in diagnostic imaging.

He has executed contracts with governments, not-for-profits, militaries, and leading medical technology and pharmaceutical companies.